Law360, New York (November 09, 2009, 1:46 PM ET) -- A federal judge has refused to de-designate documents claimed as privileged by AstraZeneca LP in a massive multidistrict litigation over the company's antipsychotic blockbuster Seroquel, further clearing the way for the roughly 6,000 cases to be remanded to transferor courts for individual discovery.
Magistrate Judge David Baker of the U.S. District Court for the Middle District of Florida issued an order Friday denying the plaintiffs' motion to de-designate as untimely, noting they did not voice their objections until nearly a year after the court clarified its...
Plaintiffs' Demand For Docs Too Late In Seroquel MDL
To view the full article, take a free trial now.
